Product Pathways
Peptide access begins with qualification and intended use.
We help qualified organizations evaluate selected peptide pathways spanning Peptide APIs, legitimate research use, and peptide-based finished dosage forms.
The purpose is not simply to display products. It is to help organizations understand what is available, what the documentation supports, and what must still be evaluated.
Product availability, documentation, permitted use, and commercial access depend on the requesting organization, peptide, partner, intended use, destination market, and applicable requirements.
Depending on the product pathway, our review may consider documented United States Food and Drug Administration (FDA) inspection histories, available evidence relevant to applicable Current Good Manufacturing Practice (CGMP) requirements, and testing through independent laboratories accredited to International Organization for Standardization/International Electrotechnical Commission (ISO/IEC) 17025:2017 within their accredited scopes.
Explore
Choose the appropriate starting point.
- 01Explore Peptide APIs
Peptide APIs
Explore qualified sourcing pathways for selected Peptide APIs, supporting documentation, and technical review.
- 02Explore Finished Dosage Form Peptides
Finished Dosage Form Peptides
Evaluate partner-enabled finished dosage form peptide development, manufacturing, packaging, documentation, and supply opportunities.
- 03Explore Research-Use Peptide APIs
Research-Use Peptide APIs
Submit legitimate research-use Peptide API requirements for qualified laboratory, research, analytical, development, or manufacturing purposes.
Peptide Portfolio
Explore our peptide portfolio.
We coordinate qualified inquiries for Peptide APIs, research-use requirements, and finished dosage form peptide products through selected manufacturers and specialized partners. Manufacturing partners and independent testing laboratories are reviewed individually by entity, facility or laboratory, applicable scope, status, and date.
Showing 24 of 24 peptides.
AOD-9604
Growth-hormone-axis peptides
BPC-157
Regenerative research peptides
CJC-1295 with DAC
Growth-hormone-axis peptides
CJC-1295 without DAC
Growth-hormone-axis peptides
Degarelix
Oncology-related peptides
Difelikefalin
Other peptide products
Ganirelix
Reproductive and endocrine peptides
GHK-Cu
Regenerative research peptides
Glatiramer Acetate
Immunomodulatory peptides
Ipamorelin
Growth-hormone-axis peptides
KPV
Immunomodulatory peptides
Liraglutide
Metabolic peptides
MOTS-C
Mitochondrial research peptides
Oxytocin
Reproductive and endocrine peptides
PT-141 / Bremelanotide
Melanocortin-related peptides
Retatrutide
Metabolic peptides
Selank
Neurology-related peptides
Semaglutide
Metabolic peptides
Semax
Neurology-related peptides
Sermorelin
Growth-hormone-axis peptides
SS-31 / Elamipretide
Mitochondrial research peptides
TB-500
Regenerative research peptides
Tesamorelin
Growth-hormone-axis peptides
Tirzepatide
Metabolic peptides
Controlled Access
Different information requires different authorization.
General capability information may be public. Product-specific availability, manufacturer information, pricing, laboratory records, batch documents, and technical materials may require organization qualification and project- or document-specific authorization.